Related Experiment Video
Updated: Feb 15, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate
Tsuyoshi Hasegawa1, Garrison J Glavich1, Mary Pahuski1
1Department of Microbiology & Molecular Cell Biology, Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia.
Abstract:
Prostate cancer afflicts 1 in 7 men and is the second leading cause of male cancer-related deaths in the United States. MicroRNAs (miRNAs), an extensive class of approximately 22 nucleotide noncoding RNAs, are often aberrantly expressed in tissues and fluids from prostate cancer patients, but the mechanisms of how specific miRNAs regulate prostate tumorigenesis and metastasis are poorly understood. Here, miR-888 was identified as a novel prostate factor that promotes proliferation and migration. miR-888 resides within a genomic cluster of 7 miRNA genes (mir-892c, mir-890, mir-888, mir-892a, mir-892b, mir-891b, mir-891a) on human chromosome Xq27.3. Moreover, as miR-888 maps within HPCX1, a locus associated with susceptibility and/or hereditary prostate cancer, it was hypothesized that additional miRNA cluster members also play functional roles in the prostate. Expression analysis determined that cluster members were similarly elevated in metastatic PC3-ML prostate cells and their secreted exosomes, as well as enriched in expressed prostatic secretions urine-derived exosomes obtained from clinical patients with high-grade prostate cancer. In vitro assays revealed that miR-888 cluster members selectively modulated PC3-derived and LNCaP cell proliferation, migration, invasion, and colony formation. Mouse xenograft studies verified miR-888 and miR-891a as pro-oncogenic factors that increased prostate tumor growth in vivo Further analysis validated RBL1, KLF5, SMAD4, and TIMP2 as direct miR-888 targets and that TIMP2 is also coregulated by miR-891a. This study provides the first comprehensive analysis of the entire miR-888 cluster and reveals biological insight.Implications: This work reveals a complex noncoding RNA network in the prostate that could be developed as effective diagnostic and therapeutic tools for advanced prostate cancer. Mol Cancer Res; 16(4); 669-81. ©2018 AACR.
Insights
This study identifies the miR-888 microRNA cluster as a key player in prostate cancer progression. These microRNAs promote tumor growth and metastasis, offering potential new diagnostic and therapeutic targets for advanced prostate cancer.
Area of Science:
- Molecular Oncology
- Noncoding RNA Biology
- Cancer Genetics
Background:
- Prostate cancer is a leading cause of cancer death in men, with poorly understood mechanisms of tumorigenesis and metastasis.
- MicroRNAs (miRNAs) are implicated in prostate cancer, but their specific roles and regulatory networks remain unclear.
- The miR-888 gene cluster on chromosome Xq27.3 is located within a region associated with hereditary prostate cancer.
Purpose of the Study:
- To investigate the role of the miR-888 microRNA cluster in prostate cancer development and progression.
- To identify specific miR-888 cluster members that promote prostate cancer cell proliferation, migration, and invasion.
- To explore the potential of these miRNAs as diagnostic and therapeutic targets for advanced prostate cancer.
Main Methods:
- Expression analysis of miR-888 cluster members in prostate cancer cell lines, exosomes, and patient urine samples.
- In vitro functional assays (proliferation, migration, invasion, colony formation) using prostate cancer cell lines.
- In vivo mouse xenograft models to assess tumor growth promotion.
- Target validation studies to identify direct targets of miR-888 and miR-891a.
Main Results:
- miR-888 and other miR-888 cluster members were elevated in metastatic prostate cancer cells, exosomes, and patient urine.
- miR-888 and miR-891a significantly promoted prostate cancer cell proliferation, migration, invasion, and tumor growth in vivo.
- RBL1, KLF5, SMAD4, and TIMP2 were identified as direct targets of miR-888, with TIMP2 also regulated by miR-891a.
Conclusions:
- The miR-888 cluster represents a novel network of microRNAs that actively promote prostate tumorigenesis and metastasis.
- Elevated expression of these miRNAs in patient samples suggests their potential as biomarkers for advanced prostate cancer.
- This research provides critical insights into noncoding RNA regulation in prostate cancer, paving the way for new diagnostic and therapeutic strategies.
Related Concept Videos
The Evidence for Evolution
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Networks
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Cluster Sampling Method
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
Vesicular Tubular Clusters
With the help of motor proteins such...

